Details for Patent: 9,440,922
✉ Email this page to a colleague
Which drugs does patent 9,440,922 protect, and when does it expire?
Patent 9,440,922 protects ALECENSA and is included in one NDA.
This patent has seventy-three patent family members in thirty-nine countries.
Summary for Patent: 9,440,922
| Title: | Tetracyclic compound |
| Abstract: | A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder: |
| Inventor(s): | Kazutomo Kinoshita, Kohsuke Asoh, Noriyuki Furuichi, Toshiya Ito, Hatsuo Kawada, Nobuya Ishii, Hiroshi Sakamoto, WooSang Hong, MinJeong Park, Yoshiyuki Ono, Yasuharu Kato, Kenji Morikami, Takashi Emura, Nobuhiro Oikawa |
| Assignee: | Chugai Pharmaceutical Co Ltd |
| Application Number: | US14/619,242 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,440,922 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 9,440,922
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,440,922
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2441753 | ⤷ Start Trial | 300876 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2441753 | ⤷ Start Trial | CA 2017 00024 | Denmark | ⤷ Start Trial |
| European Patent Office | 2441753 | ⤷ Start Trial | PA2017017 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2441753 | ⤷ Start Trial | 122017000048 | Germany | ⤷ Start Trial |
| European Patent Office | 2441753 | ⤷ Start Trial | CR 2017 00024 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
